Sfoglia per Autore
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002 Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P.
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine
2004 DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
2004 CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANNI C; NANNI P.; LOLLINI P-L
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent
2004 NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO E; MUSIANI P; FORNI G; LOLLINI P-L
Immunological prevention of a multigene cancer syndrome
2004 CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORNI G; NANNI P.; LOLLINI P-L
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role.
2006 A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. Lollini; L. Landuzzi; P. Nanni
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma.
2007 M.C. Manara; L. Landuzzi; P. Nanni; G. Nicoletti; D. Zambelli; P.L. Lollini; C. Nanni; F. Hofmann; C. García-Echeverría; P. Picci; K. Scotlandi.
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells
2007 S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Giovanni.
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
2007 C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. Iezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani.
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
2007 S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. Lollini.
Antimetastatic activity of a preventive cancer vaccine.
2007 P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S. Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini.
RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells.
2008 S. Ehlers; T. Mueck; S. Adams; L. Landuzzi; P.-L. Lollini; B. Munz
Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
2008 A.C. Berardi; S. Marsilio; C. Rofani; O. Salvucci; P. Altavista; F.M. Perla; F. Diomedi-Camassei; S. Uccini; G. Kokai; L. Landuzzi; H.P. McDowell; C. Dominici.
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model.
2009 M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Battista; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy
2009 C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. Ianzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the ApcMin mouse model in vivo.
2009 S. Sale; I.L. Fong; C. De Giovanni; L. Landuzzi; K. Brown; W.P. Steward; A.J. Gescher
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
2009 M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. Landuzzi; P. L. Lollini; G. Biasco
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
2009 Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L.; Campadelli-Fiume G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells | Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P....-L.; De Giovanni C.; Landuzzi L.; Picci P. | 2002-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine | DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M...; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells | CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANN...I C; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent | NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO ...E; MUSIANI P; FORNI G; LOLLINI P-L | 2004-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Immunological prevention of a multigene cancer syndrome | CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORN...I G; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |
| Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. | A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. L...ollini; L. Landuzzi; P. Nanni | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. | M.C. Manara; L. Landuzzi; P. Nanni; G. Nicoletti; D. Zambelli; P.L. Lollini; C. Nanni; F. Hofmann...; C. García-Echeverría; P. Picci; K. Scotlandi. | 2007-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells | S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Gio...vanni. | 2007-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
| Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. | C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. I...ezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani. | 2007-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. | S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. L...ollini. | 2007-01-01 | PATHOLOGY ONCOLOGY RESEARCH | - | 1.01 Articolo in rivista | - |
| Antimetastatic activity of a preventive cancer vaccine. | P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S.... Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells. | S. Ehlers; T. Mueck; S. Adams; L. Landuzzi; P.-L. Lollini; B. Munz | 2008-01-01 | EUROPEAN JOURNAL OF CELL BIOLOGY | - | 1.01 Articolo in rivista | - |
| Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma. | A.C. Berardi; S. Marsilio; C. Rofani; O. Salvucci; P. Altavista; F.M. Perla; F. Diomedi-Camassei;... S. Uccini; G. Kokai; L. Landuzzi; H.P. McDowell; C. Dominici. | 2008-01-01 | ANTICANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. | M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Batti...sta; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco | 2009-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy | C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. I...anzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini | 2009-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
| APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the ApcMin mouse model in vivo. | S. Sale; I.L. Fong; C. De Giovanni; L. Landuzzi; K. Brown; W.P. Steward; A.J. Gescher | 2009-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer | M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. L...anduzzi; P. L. Lollini; G. Biasco | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. | Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L....; Campadelli-Fiume G. | 2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile